FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169667471> ?p ?o ?g. }

• W2169667471 endingPage "S109" @default.
• W2169667471 startingPage "S101" @default.
• W2169667471 abstract "Several studies have demonstrated that any beneficial effect of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) on coronary events are linked to their hypocholesterolemic properties. However, since mevalonic acid (MVA), the product of the enzyme reaction, is the precursor of numerous metabolites, inhibition of HMG-CoA reductase has the potential to result in pleiotropic effects. MVA and other intermediates of cholesterol synthesis (isoprenoids) are necessary for cell proliferation and other important cell functions, hence effects other than cholesterol reduction may help to explain the antiatherosclerotic properties of statins. Recently, we provided in vitro evidence that fluvastatin, simvastatin, lovastatin, cerivastatin, but not pravastatin, dose-dependently decrease smooth muscle cells (SMC) migration and proliferation, independently of their ability to reduce plasma cholesterol. Moreover, statins are able to reduce the in vitro cholesterol accumulation in macrophages, by blocking cholesterol esterification and endocytosis of modified lipoproteins. This in vitro inhibition was completely prevented by the addition of mevalonate and partially by all-trans farnesol and all-trans geranylgeraniol, confirming the specific role of isoprenoid metabolites--probably through a prenylated protein(s)--in regulating these cellular events. The inhibitory effect of lipophilic statins on SMC proliferation has been recently shown in different models of proliferating cells such as cultured arterial myocytes and rapidly proliferating carotid and femoral intimal lesions in rabbits. Finally, ex vivo studies recently showed that sera from fluvastatin-treated patients interfere with smooth muscle cell proliferation. These results suggest that HMG-CoA reductase inhibitors exert a direct antiatherosclerotic effect in the arterial wall, beyond their effects on plasma lipids, that could translate into a more significant prevention of cardiovascular disease." @default.
• W2169667471 created "2016-06-24" @default.
• W2169667471 creator A5000676702 @default.
• W2169667471 creator A5027968457 @default.
• W2169667471 creator A5034664184 @default.
• W2169667471 creator A5045493057 @default.
• W2169667471 creator A5051086671 @default.
• W2169667471 creator A5057527708 @default.
• W2169667471 creator A5077634452 @default.
• W2169667471 creator A5083506809 @default.
• W2169667471 creator A5090989993 @default.
• W2169667471 date "1998-04-01" @default.
• W2169667471 modified "2023-10-17" @default.
• W2169667471 title "Direct vascular effects of HMG-CoA reductase inhibitors" @default.
• W2169667471 cites W1491433568 @default.
• W2169667471 cites W1574829561 @default.
• W2169667471 cites W1968034182 @default.
• W2169667471 cites W1968185522 @default.
• W2169667471 cites W1980689872 @default.
• W2169667471 cites W2005529837 @default.
• W2169667471 cites W2006073264 @default.
• W2169667471 cites W2010028742 @default.
• W2169667471 cites W2014820285 @default.
• W2169667471 cites W2017589947 @default.
• W2169667471 cites W2023553575 @default.
• W2169667471 cites W2026856116 @default.
• W2169667471 cites W2028994253 @default.
• W2169667471 cites W2030990272 @default.
• W2169667471 cites W2031734823 @default.
• W2169667471 cites W2031963160 @default.
• W2169667471 cites W2037918832 @default.
• W2169667471 cites W2039275068 @default.
• W2169667471 cites W2042709174 @default.
• W2169667471 cites W2044157711 @default.
• W2169667471 cites W2055687472 @default.
• W2169667471 cites W2057724275 @default.
• W2169667471 cites W2064060866 @default.
• W2169667471 cites W2064649898 @default.
• W2169667471 cites W2066202858 @default.
• W2169667471 cites W2069297972 @default.
• W2169667471 cites W2070780660 @default.
• W2169667471 cites W2071124826 @default.
• W2169667471 cites W2081038112 @default.
• W2169667471 cites W2081957433 @default.
• W2169667471 cites W2087098935 @default.
• W2169667471 cites W2087328245 @default.
• W2169667471 cites W2088639630 @default.
• W2169667471 cites W2089900480 @default.
• W2169667471 cites W2089906643 @default.
• W2169667471 cites W2090027585 @default.
• W2169667471 cites W2092189787 @default.
• W2169667471 cites W2105187058 @default.
• W2169667471 cites W2110431176 @default.
• W2169667471 cites W2113932898 @default.
• W2169667471 cites W2116222603 @default.
• W2169667471 cites W2119272352 @default.
• W2169667471 cites W2125149319 @default.
• W2169667471 cites W2137570167 @default.
• W2169667471 cites W2145512527 @default.
• W2169667471 cites W2147912194 @default.
• W2169667471 cites W2148096299 @default.
• W2169667471 cites W2148463229 @default.
• W2169667471 cites W2156398385 @default.
• W2169667471 cites W2159633079 @default.
• W2169667471 cites W2163523568 @default.
• W2169667471 cites W2169095915 @default.
• W2169667471 cites W2312580977 @default.
• W2169667471 cites W2338977280 @default.
• W2169667471 cites W2395019166 @default.
• W2169667471 cites W2950135326 @default.
• W2169667471 cites W4242270365 @default.
• W2169667471 cites W4247935053 @default.
• W2169667471 cites W84826734 @default.
• W2169667471 doi "https://doi.org/10.1016/s0021-9150(97)00319-5" @default.
• W2169667471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9694549" @default.
• W2169667471 hasPublicationYear "1998" @default.
• W2169667471 type Work @default.
• W2169667471 sameAs 2169667471 @default.
• W2169667471 citedByCount "200" @default.
• W2169667471 countsByYear W21696674712012 @default.
• W2169667471 countsByYear W21696674712013 @default.
• W2169667471 countsByYear W21696674712014 @default.
• W2169667471 countsByYear W21696674712015 @default.
• W2169667471 countsByYear W21696674712016 @default.
• W2169667471 countsByYear W21696674712017 @default.
• W2169667471 countsByYear W21696674712018 @default.
• W2169667471 countsByYear W21696674712020 @default.
• W2169667471 countsByYear W21696674712022 @default.
• W2169667471 crossrefType "journal-article" @default.
• W2169667471 hasAuthorship W2169667471A5000676702 @default.
• W2169667471 hasAuthorship W2169667471A5027968457 @default.
• W2169667471 hasAuthorship W2169667471A5034664184 @default.
• W2169667471 hasAuthorship W2169667471A5045493057 @default.
• W2169667471 hasAuthorship W2169667471A5051086671 @default.
• W2169667471 hasAuthorship W2169667471A5057527708 @default.
• W2169667471 hasAuthorship W2169667471A5077634452 @default.
• W2169667471 hasAuthorship W2169667471A5083506809 @default.
• W2169667471 hasAuthorship W2169667471A5090989993 @default.

• next